10X Genomics Inc vs Financial Select Sector SPDR Fund — how do they compare? 10X Genomics Inc trades at $58.61 (market cap $7.64B), while Financial Select Sector SPDR Fund trades at $57.77. Which is the better fit depends on your goals.
| TXG | XLF | |
|---|---|---|
Market Cap | $7.64B | — |
Sector | Health | — |
52-Week High | $58.57 | $58.01 |
52-Week Low | $11.34 | $47.80 |
Enterprise Value | $7.17B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLF trades at $57.60, down 0.35% on the day, with a bullish technical signal driven by moving averages and strong momentum indicators. The ETF recently touched an all-time high, supported by robust inflows into financial sector ETFs and strong Q2 earnings from major banks. A dividend of $0.19 is scheduled for June 2026, adding income appeal.
Outlook remains positive given sector strength and institutional interest, though overbought RSI levels suggest near-term consolidation risks. Key opportunities include diversification benefits and yield; risks involve interest rate sensitivity and market volatility.
Trailing returns across standard periods
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →